CRDF
Cardiff Oncology, Inc.
-0.04 (-2.59%)1.32USD457K成交股數102M市值–本益比(近四季)201.4股價營收比-14.1%營收年增(近四季)2026-11-12下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 104K-14% | 41K-62% | 243K+47% | 120K-26% | 121K-41% | 109K-30% | 165K+17% | 163K+51% | 205K | 156K | 141K | 108K |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 5.9M | 6.8M | 5.1M | 8.2M | 11.6M | 10.5M | 9.6M | 9.5M | 8.0M | 7.8M | 8.0M | 8.0M |
| 銷售管理費用 | 3.8M | 6.1M | 3.0M | 3.9M | 3.3M | 4.0M | 3.1M | 3.2M | 3.1M | 2.7M | 2.9M | 4.3M |
| 營業利益 | −9.6M-35% | −12.9M-11% | −7.8M-38% | −12.0M-5% | −14.8M+35% | −14.4M+39% | −12.6M+16% | −12.5M+3% | −10.9M | −10.3M | −10.8M | −12.2M |
| 營業利益率 | -9,245.2% | -31,341.5% | -3,221.0% | -9,978.3% | -12,212.4% | -13,194.5% | -7,637.0% | -7,696.3% | -5,333.2% | -6,623.1% | -7,673.8% | -11,303.7% |
| 稅後淨利 | −9.2M-34% | −12.3M-8% | 38.6M-426% | −11.3M-4% | −13.9M+39% | −13.4M-142% | −11.9M+22% | −11.8M+6% | −10.0M | 32.1M | −9.7M | −11.2M |
| 淨利率 | -8,876.9% | -30,109.8% | 15,880.3% | -9,381.7% | -11,523.1% | -12,324.8% | -7,184.8% | -7,225.8% | -4,883.4% | 20,552.9% | -6,901.4% | -10,324.1% |
| 稀釋 EPS | -0.14-33% | -0.18-10% | -0.11-56% | -0.17-35% | -0.21-5% | -0.20-5% | -0.25+14% | -0.26+4% | -0.22 | -0.21 | -0.22 | -0.25 |
| 稀釋股數 | 68.4M | 68.3M | 66.8M | 66.9M | 66.5M | 66.5M | 46.9M | 44.8M | 44.7M | 44.7M | 44.7M | 44.7M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 9.2M | 8.5M | 17.5M | 10.1M | 10.8M | 24.1M | 13.0M | 25.5M | 18.7M | 21.7M | 15.2M | 19.4M |
| 應收帳款 | 189K | 191K | 182K | 254K | 526K | 405K | 618K | 451K | 393K | 288K | 198K | 161K |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 37.3M | 49.2M | 61.9M | 63.8M | 75.7M | 84.8M | 62.9M | 66.1M | 74.0M | 81.6M | 88.5M | 97.5M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 10.8M | 14.5M | 16.5M | 15.0M | 17.1M | 13.9M | 13.5M | 13.7M | 13.1M | 11.9M | 10.6M | 10.9M |
| 股東權益 | 26.5M | 34.7M | 45.4M | 48.8M | 58.6M | 70.9M | 49.4M | 52.4M | 60.9M | 69.7M | 77.8M | 86.6M |
| 負債比 | 28.9% | 29.4% | 26.7% | 23.5% | 22.6% | 16.4% | 21.5% | 20.7% | 17.8% | 14.6% | 12.0% | 11.2% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −12.3M-4% | – | – | – | −12.8M | – | – | −7.7M | – | – | – |
| 資本支出 | – | – | – | – | – | – | – | – | 80K | – | – | – |
| 自由現金流 | – | – | – | – | – | – | – | – | −7.8M | – | – | – |
| 折舊攤銷 | – | 87K | – | – | – | 93K | – | – | 102K | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | -3,814.6% | – | – | – |
營收拆解 2020 年度 10-K 的分部揭露 · 年增對前一年度
產品／服務2020 年度 · 366K
| Royalty | 366K | 100.0% | +50.5% |
|---|
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 593K | -13.2% | −46K | -7.7% | -0.69 | −38.0M |
| FY2024 | 683K | +40.0% | −45K | -6.7% | -0.95 | −37.8M |
| FY2023 | 488K | +26.4% | −41K | -8.5% | -0.93 | −31.5M |
| FY2022 | 386K | +7.5% | −38.7M | -10,026.9% | -0.89 | −34.8M |
| FY2021 | 359K | -1.9% | −28.3M | -7,880.5% | -0.73 | −23.2M |
| FY2020 | 366K | +49.6% | −19.3M | -5,275.1% | -1.08 | −16.5M |
| FY2019 | 245K | -35.3% | −16.4M | -6,709.7% | -2.80 | −13.3M |
| FY2018 | 378K | – | −16.5M | -4,351.1% | -8.26 | −13.2M |